Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether he has plans to undertake a public consultation with stakeholders on the development of the National Genomic Healthcare Strategy.

In developing the National Genomic Healthcare Strategy, the Government will undertake wide ranging and comprehensive engagement, involving detailed discussions with patient and public groups, researchers, charities and industry. This will be guided by the National Genomics Board, which oversees the Government’s work to maintain the United Kingdom’s position as the world’s leading centre for genomic medicine and research.

Although this does not involve a formal public consultation document, patients and the public will be key to developing the strategy, and we will utilise a wide range of existing public and patient engagement groups to do so.